IVD

Supporting the Digital Movement of Diagnostics Data

Beckman Coulter employs informatics to automate sample processing and the delivery of testing results.

Thermo Fisher Rumored to Be Interested in Acquiring Qiagen

Waltham, MA-based Thermo Fisher Scientific could be acquiring Qiagen, according to a report from Bloomberg citing people with knowledge of the matter.

Guardant Eyes Approval for Lunar Through ECLIPSE

The liquid biopsy pioneer is developing the Lunar-2 test, which is being evaluated for early colorectal cancer screening.

The Journey of Developing a Novel Point-Of-Care Diagnostic

Kfir Oved co-founder and CTO of MeMed is set to describe the decade-long journey of trying to tackle the global healthcare challenge of antibiotics misuse and the rise of antimicrobial resistance at the BioMed Device San Jose next month.

Could Testing for RNA in Addition to DNA Make a Difference in Cancer?

Ambry Genetics’s +RNAinsight performs both DNA and RNA genetic testing at the same time, which according to a pilot study increases identification of disease-causing DNA mutations.

FDA Gives Nod for Breakthrough HIV Test

FDA authorized the marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next-generation sequencing technology.

Diagnosing Sepsis in Minutes

Cytovale has just received new funding through HHS’s Biomedical Advanced Research and Development Authority (BARDA) to advance its rapid diagnostics platform employing microfluidics, high-speed imaging, and machine learning.

Blood Test Can Detect Breast Cancer 5 Years Before Symptoms Occur

Researchers at the University of Nottingham presented findings about the test at the 2019 NCRI Cancer Conference.

Grail Stays at Forefront of Liquid Biopsy Conversation with New Results

The Menlo Park, CA-based company announced data validating the performance of its investigational multi-cancer early detection blood test for the first time in an independent cohort of participants.

A Blood Test for Brain Cancer with a Dash of AI Added

Researchers for the University of Strathclyde have developed the test, which uses infrared light to produce a "bio-signature" of a blood sample and applies artificial intelligence to check for the signs of cancer.

Qiagen and Illumina in It for the Long Haul with 15-year Collaboration

The two firms want to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics. The news comes as Qiagen’s CEO Peer Schatz announced he is stepping down.

New Breath Test Detects Opioid Use

A test to detect opioid drugs in exhaled breath has been developed by engineers and physicians at the University of California, Davis. A breath test could be useful in caring for chronic pain patients as well as for checking for illegal drug use.

Can Bowel Cancer Screening Reduce Patient Death?

While a new study from the University of Australia points to the benefits of the use of pre-diagnostic colonoscopies, some patients are still hesitant about the procedure. This has caused companies to develop less invasive bowel cancer screening methods.

Roche Packs New FDA-Approved Test in Its Arsenal

The Basel, Switzerland-based company’s cobas Babesia test is a qualitative in vitro nucleic acid screening test for the direct detection of Babesia DNA and RNA in whole blood specimens from individual human blood donors.

Abbott’s FreeStyle Libre Catches Sanofi’s Eye in New Collaboration

Paris-based Sanofi will work with Abbott Laboratories to integrate glucose sensing and insulin delivery technologies to help improve diabetes management in patients. Abbott’s Freestyle Libre – a device that brought in $430 million in revenue for 2Q19, will be at the heart of the collaboration.

OncoCell MDx Rides the Liquid Biopsy Wave with New Financing

The Royal Oak, MI-based company has raised $22.2 million in a series B round and is developing a test for the detection of prostate cancer. Executives from OncoCell said the test could be available late next year.

Qmed Search Form